Oxford BioMedica, Microsoft join on digital tools to optimize lentiviral production

In the latest example of how digital computing is increasingly interfacing with biomanufacturing to optimize yields and purity, Oxford BioMedica on Tuesday entered a

Read the full 249 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE